Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsDivislaboratories

    Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More

    Jump to

    • Here are fundamental trading ideas from SP Tulsian

      In an interview to CNBC-TV18's Latha Venkatesh, Anuj Singhal, and Surabhi Upadhyay, SP Tulsian of sptulsian.com shared his readings and outlook on market and specific stocks and sectors.

    • Bull's Eye: Buy Axis Bank, Ajanta Pharma, Ashok Leyland, Bata, Divis Lab

      Gaurav Ratnaparkhi of Sharekhan advises selling Oriental Bank of Commerce Future with a target of Rs 120.50.

    • Buy Tata Global Beverage, Divis Labs, Ajanta Pharma, Ujjivan Financial: Mitessh Thakkar

      Mitessh Thakkar of miteshthacker.com recommends buying Tata Global Beverage, Divis Labs, Ajanta Pharma and Ujjivan Financial.

    • Buy Rajratan Global Wire: SP Tulsian

      Watch the interview of SP Tulsian of sptulsian.com with Anuj Singhal, Latha Venkatesh and Surabhi Upadhyay on CNBC-TV18. He shared his readings and outlook on Rajratan Global Wire stock.

    • Buy MGL, Simplex Infra, Divis Labs, Balkrishna Industries, Tata Motors, Aban Offshore: Ashwani Gujral

      Ashwani Gujral of ashwanigujral.com suggests buying Mahanagar Gas, Simplex Infra, Divis Labs, Balkrishna Industries, Tata Motors and Aban Offshore.

    • Buy, Sell, Hold: 6 stocks are being tracked by brokerages today

      Vedanta, Glenmark and Hindalco, among others, on the radar of investors on Friday.

    • Sell Capital First, LIC Housing; buy Balkrishna Industries, Hindalco, UltraTech: Sudarshan Sukhani

      Sudarshan Sukhani of s2analytics.com is of the view that one can sell Capital First and LIC Housing Finance and can buy Balkrishna Industries, Hindalco Industries and UltraTech Cement.

    • Buy Bank of India, Divis Laboratories, Mahanagar Gas, Indiabulls Real Estate: Sandeep Wagle

      Sandeep Wagle of powermywealth.com recommends buying Bank of India and Divis Laboratories.

    • Buy Ashok Leyland, Divis Laboratories, RIL, Torrent Power; sell LIC Housing: Sudarshan Sukhani

      Sudarshan Sukhani of s2analytics.com is of the view that one can buy Ashok Leyland, Divis Laboratories, Reliance Industries and Torrent Power and can sell LIC Housing Finance.

    • Buy Divis Laboratories, Karnataka Bank; sell Zee Entertainment: Gaurav Bissa

      Gaurav Bissa, Derivatives Analyst at LKP Securities is of the view that one can buy Divis Laboratories and Karnataka Bank and can sell Zee Entertainment futures.

    • Buy Ajanta Pharma, Wockhardt, UPL, Bajaj Finance: Ashwani Gujral

      Ashwani Gujral of ashwanigujral.com recommends buying Ajanta Pharma, Wockhardt, UPL and Bajaj Finance.

    • Top 10 technical picks for Muhurat Trading which can return up to 40% in Samvat 2074

      The Nifty50 rose nearly 1600 points in Samvat 2073 and expectations are that it could witness some profit booking in the near term. However, the long-term trend remains intact and the index is poised to hit 10,500-11,000 in Samvat 2074.

    • These 7 stocks that saw double-digit growth in free cash flow over last 4 fiscals

      Moneycontrol ran an analysis of companies which generated consistently double-digit growth in cash flows in the last four fiscal years.

    • Divis Laboratories may slip to Rs 750, Gail may test Rs 485-500: Ashwani Gujral

      Ashwani Gujral of ashwanigujral.com feels that Divis Laboratories may slip to Rs 750.

    • Buy Divis Laboratories, Bharat Electronics; sell Oil India: Ashwani Gujral

      Ashwani Gujral of ashwanigujral.com is of the view that one may buy Divis Laboratories and Bharat Electronics.

    • Sell Divis Lab, HPCL; buy Motilal Oswal Financial: Ashwani Gujral

      Ashwani Gujral of ashwanigujral.com is of the view that one may buy Motilal Oswal Financial Services.

    • Fund houses still cautious on pharmaceutical sector: HDFC Securities

      In an interview to CNBC-TV18, Amey Chalke, Research Analyst of HDFC Securities spoke about the latest happenings in pharma sector and shared his views on various stocks.

    • Oracle Financial Services Software may test Rs 3600: Prakash Gaba

      Prakash Gaba of prakashgaba.com feels that Oracle Financial Services Software may test Rs 3600.

    • Hold Divis Laboratories, target Rs 1000: Sandeep Wagle

      Sandeep Wagle of powermywealth.com is of the view that one may hold Divis Laboratories.

    • Short Divis Laboratories, buy DHFL: Ashwani Gujral

      Ashwani Gujral of ashwanigujral.com advises shorting Divis Laboratories.

    • These 20 stocks rose 5-30% when fear and panic hit D-Street

      The buying interest around TV Today Network picked up momentum in the last three months which saw its shares rising a little over 50 percent in the same period.

    • Regulatory issues should reduce going ahead for DRL: Edelweiss Sec

      Pharma stocks have been on an upward trend. In an interview to CNBC-TV18, Deepak Malik, Pharma Analyst of Edelweiss Securities discussed what is happening in the sector.

    • Buy Bharti Airtel, Dr Reddy's Labs, Bharat Financial; sell Hero Moto: Ashwani Gujral

      Ashwani Gujral of ashwanigujral.com is of the view that one can buy Bharti Airtel, Dr Reddy's Labs and Bharat Financial Inclusion and can sell Hero MotoCorp and Reliance Capital.

    • Buy NBCC, Divis Laboratories: Sandeep Wagle

      Sandeep Wagle of powermywealth.com advises buying NBCC and Divis Laboratories.

    • Sell M&M; buy Ashok Leyland, Colgate Palmolive, Divis Laboratories: Sudarshan Sukhani

      Sudarshan Sukhani of s2analytics.com is of the view that one can sell M&M and buy Ashok Leyland, Colgate Palmolive and Divis Laboratories.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347